Prolonged Exposure to Oxaliplatin during HIPEC Improves Effectiveness in a Preclinical Micrometastasis Model.
Seyfried N, Yurttas C, Burkard M, Oswald B, Tolios A, Herster F, Kauer J, Jäger T, Königsrainer I, Thiel K, Quante M, Rammensee HG, Venturelli S, Schwab M, Königsrainer A, Beckert S, Löffler MW.
Seyfried N, et al. Among authors: tolios a.
Cancers (Basel). 2022 Feb 24;14(5):1158. doi: 10.3390/cancers14051158.
Cancers (Basel). 2022.
PMID: 35267468
Free PMC article.